Cargando…
Retroviral Integrations in Gene Therapy Trials
γ-Retroviral and lentiviral vectors allow the permanent integration of a therapeutic transgene in target cells and have provided in the last decade a delivery platform for several successful gene therapy (GT) clinical approaches. However, the occurrence of adverse events due to insertional mutagenes...
Autores principales: | Biasco, Luca, Baricordi, Cristina, Aiuti, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321603/ https://www.ncbi.nlm.nih.gov/pubmed/22252453 http://dx.doi.org/10.1038/mt.2011.289 |
Ejemplares similares
-
Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell
por: Biasco, Luca, et al.
Publicado: (2011) -
Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy
por: Biasco, Luca, et al.
Publicado: (2017) -
IS-Seq: a bioinformatics pipeline for integration sites analysis with comprehensive abundance quantification methods
por: Yan, Aimin, et al.
Publicado: (2023) -
Integration Site and Clonal Expansion in Human Chronic Retroviral Infection and Gene Therapy
por: Niederer, Heather A., et al.
Publicado: (2014) -
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery
por: Anson, Donald S
Publicado: (2004)